Lindsey Sloan, MD, PhD

Dr. Sloan is an Assistant Professor, Medical Student Director and Co-lead of the Department Diversity, Equity and Inclusion Committee  in the Department of Radiation Oncology at the University of Minnesota, and is a Masonic Scholar with the Masonic Cancer Center. Her clinical practice specializes in the treatment of tumors of the brain (primary brain tumors and brain metastases) with radiotherapy.

Dr. Sloan completed her undergraduate studies at the University of Pennsylvania. After completing the MD/PhD Program at The Lewis Katz School of Medicine at Temple University and her residency in Radiation Oncology at the Johns Hopkins University School of Medicine, where she was mentored by Dr. Lawrence Kleinberg, Dr. Sudipto Ganguly, and Dr. Drew Pardoll, Dr. Sloan was recruited to the University of Minnesota’s Department of Radiation Oncology in 2020. In 2021, she was appointed the co-lead of the Department of Radiation Oncology Diversity, Equity and Inclusion Committee, and in 2023, she was appointed as the Medical Student Director for the Department of Radiation Oncology. Also in 2023, she became an Executive Committee Member of the Brain Tumor Program at the University of Minnesota. Dr. Sloan became a member of both the NRG Oncology Brain Tumor General Committee and the NRG Oncology Radiation Oncology Committee in 2024.

Dr. Sloan’s primary area of research is the systemic effect of cancer therapy. As a physician-scientist, she leads a translational research laboratory within the University of Minnesota Brain Tumor Program (UMBTP), focused on understanding the role of myeloid cells in primary brain tumors. Dr. Sloan is particularly interested in the impact of radiotherapy on deleterious peripheral blood myeloid cell populations in patients with brain tumors. The overall goal of her translational science program is to personalize radiation therapy based on systemic immune biomarkers. Dr. Sloan is the Principal Investigator (PI) of multiple interventional and observational clinical trials.